NOV 25, 2019 10:01 AM PST

Darobactin: Promising New Drug to Combat Antibiotic Resistance

WRITTEN BY: Annie Lennon

Every year, around 700,000 people are estimated to die from drug-resistant infections thanks to our overuse of antibiotics both in agriculture and medicine. With this figure estimated to grow into the millions within the coming decades, researchers are scrambling to find new ways to treat infections. Now, researchers from Justus Liebig University Giessen have discovered a new peptide from the gut of a parasitic worm that may be able to help. 

Known as Darobactin, the peptide works against gram negative bacteria which, due to their highly restrictive cell walls, are immune to most antibiotics. Gram negative bacteria are common; examples including Escherichia coli (E. Coli) and Klebsiella pneumoniae (pneumonia) which have become immune to most treatment due to this cellular feature, thus prompting heavy research into tackling gram negative bacteria. 

The epitome of two years of research, Darobactin emerged as a possible antibiotic from analyzing the Photorhabdus bacteria, found in the gut of a small parasitic worm known as a nematode. The worm first caught researchers attention due to its ability to feed on insects, targeting their larvae and releasing bacteria that combat pathogens similar to those present in the human gut. Isolating the worm’s gut bacteria, the researchers were then able to find Darobactin which, after screening, was then experimented with to treat bacterial infections common in humans. 

So far, usage of the peptide has been successful. In experiments with mice, it has successfully managed to eradicate several bacterial strains including previously antibiotic-resistant strains of E Coli and pneumonia. From examining it in the lab, researchers saw that it works by binding to the BamA protein, found on the external membrane of gram negative bacteria. This then leads the bacteria to malfunction, and eventually die off. 

According to Professor Till Schaeberie from the Institute of Insect Biotechnology, “"It is particularly interesting to note that this previously unknown weak point is located on the outside of the bacteria where substances can easily reach it." 

Although Darobactin shows a lot of promise as an upcoming antibiotic, as human trials have yet to be conducted, it will take some time for the peptide to be able to treat human infections. Despite this however, the researchers remain optimistic that their experiments with Darobactin demonstrate a clear potential for its development as a therapeutic


Sources: Science Alert, Science Daily and Nature

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
SEP 15, 2020
Drug Discovery & Development
Turmeric Better than Placebo for Osteoarthritis Pain
SEP 15, 2020
Turmeric Better than Placebo for Osteoarthritis Pain
Researchers from the University of Tasmania in Australia have found that an extract from turmeric is more effective than ...
OCT 01, 2020
Drug Discovery & Development
HPV Vaccine Protects Against Cervical Cancer, Large Study Finds
OCT 01, 2020
HPV Vaccine Protects Against Cervical Cancer, Large Study Finds
It has been known for some time that the HPV vaccine protects against human papillomavirus infection, genital warts, and ...
OCT 07, 2020
Technology
Millimeter-Precision Drug Delivery
OCT 07, 2020
Millimeter-Precision Drug Delivery
It is almost impossible to deliver targeted drug therapy via the bloodstream without reaching the entire brain and body ...
OCT 10, 2020
Drug Discovery & Development
Fishnet of Nanoparticles Traps Drug Molecules
OCT 10, 2020
Fishnet of Nanoparticles Traps Drug Molecules
‘Fishnet’ Nanoparticles Traps Drug Molecules A team at Northwestern University have casted a net of nanopart ...
OCT 13, 2020
Drug Discovery & Development
Uses of Tandem Mass Spectrometry (TMS)
OCT 13, 2020
Uses of Tandem Mass Spectrometry (TMS)
What is tandem mass spectrometry? A powerful analytical tool that is capable of characterizing complex mixtures in drug ...
NOV 06, 2020
Drug Discovery & Development
New Vaccine Shows Promise for Herpes
NOV 06, 2020
New Vaccine Shows Promise for Herpes
The World Health Organization estimates that over 500 million people have Herpes Simplex Virus Type 2 (HSV-2), a sexuall ...
Loading Comments...